Subsequently, they assessed the efficacy of ADV-ApoA1 in inhibiting TNBC growth and metastasis in several mouse models, including orthotopic breast cancer, spontaneous breast cancer, and human breast cancer xenografts. This evidence concerns the gene APOA1 and breast cancer.